Skip to main content
Pay Bill Portals

Circulating tumor DNA monitoring in patients with advanced urothelial carcinoma treated with Enfortumab Vedotin +/- Pembrolizumab

Published Date

Reyes KR, Jindal T, Mitchell B, et al. ASCO Annual Meeting 2025, Chicago, IL. May 30 - June 3, 2025.

Download PDF